Company
4D Molecular Therapeutics
Powering The Future Of Genetic Medicines
Also known as D Molecular Therapeutics, Inc
- Status
- Operatingas of 2026-09-19Source (opens in a new tab)
- Business model
- B2B
- Legal name
- D Molecular Therapeutics, Inc
- 4dmoleculartherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients.
Funding snapshot
- Total raised
- $109MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $90M2018-08-27
Funding rounds
- Round, 2018
- $90M2018-08-27, SEC form D sold, 31 investors
- Round, 2015
- $11.6M2015-10-06, SEC form D sold, 2 investors
- Round, 2015
- $7M2015-08-11, SEC form D sold, 1 investor
Loading relationship preview